Claritev (CTEV) Other financing activities (2020 - 2025)
Claritev's quarterly Other financing activities came in at $4.3 million in Q1 2025, up 593.82% quarter-over-quarter from $615000.0 in Q4 2024.
Claritev has reported Other financing activities for 3 years, with the latest figure at $4.3 million in Q1 2025.
- For the quarter ending Q1 2025, Other financing activities changed N/A year-over-year to $4.3 million; the trailing twelve-month figure through Dec 2025 stood at $4.3 million (up 593.82% YoY), and the FY2025 full-year result was $4.3 million, up 593.82% from the prior year.
- Other financing activities for Q1 2025 stood at $4.3 million, up from $615000.0 in the prior quarter.
- The five-year high for Other financing activities was $4.3 million in Q1 2025, with the low at $615000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Claritev | 456.62 Mn | 428.62 Mn | 175.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 4.27 Mn |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | 615,000.00 |
| Dec 31, 2024 | 615,000.00 |
| Dec 31, 2020 | 22.89 Mn |
| Dec 31, 2020 | 22.89 Mn |
| Mar 31, 2020 | 602,020.00 |
| Mar 31, 2020 | 602,020.00 |